Sign in

CIK 0001662774 · Non-accelerated filer<br>Smaller reporting company

IRulya Therapeutics Inc.

Sign in to watch
Ticker
IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
901024039
Phone
203-208-8994
Business address
101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 8-K Event Regulation FD disclosure
  10. SCHEDULE 13G Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G Stake Statement of Beneficial Ownership
  12. 8-K Event Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure · Other events
  13. S-8 Other Securities Offered to Employees in Benefit Plans
  14. 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results
  15. DEFA14A Proxy Proxy Materials
  16. 8-K Event Executive or director change
  17. 8-K Event Acquisition or sale completed · Executive or director change
  18. 8-K Event Delisting notice
  19. 8-K Event Executive or director change
  20. DEF 14A Proxy Proxy Statement

Page 1 of 24 · 462 filings